Rifat Pamukcu Aprea Therapeutics, Inc. (APRE) insider trading activity
Rifat Pamukcu is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 5,446 shares of APRE, which is worth approximately $9,149. The most recent transaction as insider was on Jun 05, 2025, when has been sold 1,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
5.45K
23.74%
3M change
23.74%
12M change
Total Value Held
$9,149
Rifat Pamukcu Transaction History
RP
Rifat Pamukcu
Director
Boston, MA